Literature DB >> 17581868

Breaking new ground to build bone.

Lauren A Kingsley1, John M Chirgwin, Theresa A Guise.   

Abstract

Mesh:

Substances:

Year:  2007        PMID: 17581868      PMCID: PMC1904128          DOI: 10.1073/pnas.0704357104

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  19 in total

Review 1.  Integrins and signaling in osteoclast function.

Authors:  L T Duong; P Lakkakorpi; I Nakamura; G A Rodan
Journal:  Matrix Biol       Date:  2000-05       Impact factor: 11.583

Review 2.  RAFTK/Pyk2-mediated cellular signalling.

Authors:  H Avraham; S Y Park; K Schinkmann; S Avraham
Journal:  Cell Signal       Date:  2000-03       Impact factor: 4.315

Review 3.  Sclerostin and Wnt signaling--the pathway to bone strength.

Authors:  Susan M Ott
Journal:  J Clin Endocrinol Metab       Date:  2005-12       Impact factor: 5.958

Review 4.  Parathyroid hormone as an anabolic therapy for women and men.

Authors:  J P Bilezikian; M R Rubin; J S Finkelstein
Journal:  J Endocrinol Invest       Date:  2005       Impact factor: 4.256

5.  Stimulation of bone formation in vitro and in rodents by statins.

Authors:  G Mundy; R Garrett; S Harris; J Chan; D Chen; G Rossini; B Boyce; M Zhao; G Gutierrez
Journal:  Science       Date:  1999-12-03       Impact factor: 47.728

6.  Calcitonin induces podosome disassembly and detachment of osteoclasts by modulating Pyk2 and Src activities.

Authors:  Jia-Fwu Shyu; Chung Shih; Chiung-Ying Tseng; Chi-Hung Lin; Der-Tzong Sun; Hsiao-Tung Liu; Hui-Chu Tsung; Tien-Hua Chen; Ru-Band Lu
Journal:  Bone       Date:  2007-01-26       Impact factor: 4.398

7.  Reconciling the roles of FAK in osteoblast differentiation, osteoclast remodeling, and bone regeneration.

Authors:  Jae-Beom Kim; Philipp Leucht; Cynthia A Luppen; Yu Jin Park; Hilary E Beggs; Caroline H Damsky; Jill A Helms
Journal:  Bone       Date:  2007-03-13       Impact factor: 4.398

8.  PYK2 autophosphorylation, but not kinase activity, is necessary for adhesion-induced association with c-Src, osteoclast spreading, and bone resorption.

Authors:  Parvi T Lakkakorpi; Andrew J Bett; Lorraine Lipfert; Gideon A Rodan; Le T Duong
Journal:  J Biol Chem       Date:  2003-01-03       Impact factor: 5.157

Review 9.  Update in osteoporosis and metabolic bone disorders.

Authors:  Dolores Shoback
Journal:  J Clin Endocrinol Metab       Date:  2007-03       Impact factor: 5.958

Review 10.  The use of parathyroid hormone in the treatment of osteoporosis.

Authors:  Monica Girotra; Mishaela R Rubin; John P Bilezikian
Journal:  Rev Endocr Metab Disord       Date:  2006-06       Impact factor: 9.306

View more
  3 in total

Review 1.  Gene targeting to the stroma of the prostate and bone.

Authors:  Roger S Jackson; Omar E Franco; Neil A Bhowmick
Journal:  Differentiation       Date:  2008-05-20       Impact factor: 3.880

2.  Targeting PYK2 mediates microenvironment-specific cell death in multiple myeloma.

Authors:  M B Meads; B Fang; L Mathews; J Gemmer; L Nong; I Rosado-Lopez; T Nguyen; J E Ring; W Matsui; A R MacLeod; J A Pachter; L A Hazlehurst; J M Koomen; K H Shain
Journal:  Oncogene       Date:  2015-09-21       Impact factor: 9.867

Review 3.  The Calcium-Sensing Receptor and Integrins in Cellular Differentiation and Migration.

Authors:  Sujeenthar Tharmalingam; David R Hampson
Journal:  Front Physiol       Date:  2016-05-26       Impact factor: 4.566

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.